PCSK9 抗体 (C-Term)
-
- 抗原 See all PCSK9 抗体
- PCSK9 (Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9))
-
抗原表位
- C-Term
-
适用
- 人
-
宿主
- 山羊
-
克隆类型
- 多克隆
-
标记
- This PCSK9 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 原理
- Goat polyclonal antibody raised against synthetic peptide of PCSK9.
- 序列
- CRSRHLAQAS QELQ
- 交叉反应
- 人
- 免疫原
- A synthetic peptide corresponding to C-terminus of human PCSK9.
- Top Product
- Discover our top product PCSK9 Primary Antibody
-
-
- 应用备注
-
ELISA (1:16000)
Western Blot (0.3 μg/mL)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-6 μg/mL)
The optimal working dilution should be determined by the end user. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5 mg/mL
- 缓冲液
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia." in: Human molecular genetics, Vol. 14, Issue 9, pp. 1161-9, (2005) (PubMed).
: "
-
Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia." in: Human molecular genetics, Vol. 14, Issue 9, pp. 1161-9, (2005) (PubMed).
-
- 抗原
- PCSK9 (Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9))
- 别名
- PCSK9 (PCSK9 产品)
- 别名
- FH3 antibody, HCHOLA3 antibody, LDLCQ1 antibody, NARC-1 antibody, NARC1 antibody, PC9 antibody, AI415265 antibody, AI747682 antibody, Narc1 antibody, proprotein convertase subtilisin/kexin type 9 antibody, proprotein convertase subtilisin/kexin type 9 L homeolog antibody, PCSK9 antibody, pcsk9.L antibody, pcsk9 antibody, Pcsk9 antibody
- 基因ID
- 255738
-